Stroke (CVA) or TIANCT07624773
Pnf Techniques vs Mirror Therapy
A study testing Mirror therapy and PNF in people with Stroke (CVA) or TIA, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
Trial summary
to check the effectiveness of mirror therapy and pnf techniques on lower limb mobility in stroke patients Read more about this study
- Who is it for?
- Ages 40 to 65 years
- Conditions the study is for
- Stroke (CVA) or TIA
- What is being tested?
- Mirror therapy and PNF
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Aug 2025to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 to 65 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Participants must be stroke patients of age 40-65 years
- Subacute Stroke
- Brunnstorm stage 3 or more than 3
Who cannot join
- Acute stroke
- Patient unwilling to participate in study
- Cardiovascular instability
Trial locations and contacts
1 site in 1 country.
Pakistan1 site
Elite College of Management Sciences, Gujranwala
Guiranwala, Punjab Province, 52200
About this study
Official title: Effectiveness of Pnf Techniques and Mirror Therapy for Lower Limb Mobility in Subacute Stroke Patients
to check the effectiveness of mirror therapy and pnf techniques on lower limb mobility in stroke patients
- Conditions
- Stroke (CVA) or TIA
- Being tested
- Mirror therapy, PNF
- Keywords
- Stroke Rehabilitation, Mirror Movement therapy, Muscle Stretching Exercise
- Medical subject headings
- Stroke
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mirror therapyOther
along with baseline therapeutic exercises treatment, mirror theapy is given to group 1 with 2 sets of 10 repetitions
PNFOther
along with baseline therapeutic treatment ,PNF is given to group 2 with 2 sets of 10 repetitions
| Study group | Role | What they receive |
|---|---|---|
| Mirror therapy | Experimental | Mirror therapy used for cognitive training in stroke patients Receives: Other: Mirror therapy |
| PNF | Experimental | PNF used for mobility training Receives: Other: PNF |
What is being measured
The primary outcome is the main question the study is designed to answer.
fugl-meyer assesment scale
fugl-meyer assesment scale is used to asses motor recovery and functional in stroke patient . The results calculate on the basis of range 0-10 (severe), 11-20 (moderate), 21-28 (mild).
Measured: 4 weeks
Secondary outcomes (1)
Berg Balance Scale
Berg Balance Scale is used to assess balance and coordination.The result calculate on the basis of ranges 0-20 (severe),21-40 (moderate), 41-56 (severe).
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2026
- Study start1 Aug 2025
- Primary completion10 Apr 2026
- Study completion30 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Stroke (CVA) or TIAStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, Pakistan
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Imran Rafiq, PhD Rehabilitation Sciences, Study director, Elite College of Management Sciences, Gujranwala
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07624773
- Sponsor's protocol ID
- 2021-066503
- Status last verified
- May 2026
- First submitted
- 20 May 2026
- Last updated
- 3 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Pnf Techniques and Mirror Therapy for Lower Limb Mobility in Subacute Stroke Patients
- ClinicalTrials.gov ID
- NCT07624773
- Acronym / sponsor ID
- 2021-066503
- Conditions
- Stroke (CVA) or TIA
- Keywords
- Stroke Rehabilitation, Mirror Movement therapy, Muscle Stretching Exercise
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- Elite College of Management Sciences, Gujranwala, PakistanUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 10 Apr 2026 (actual)
- Study completion
- 30 Apr 2026 (actual)
- First posted
- 3 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
to check the effectiveness of mirror therapy and pnf techniques on lower limb mobility in stroke patients
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mirror therapy | Experimental | Other: Mirror therapyMirror therapy used for cognitive training in stroke patients |
| PNF | Experimental | Other: PNFPNF used for mobility training |
Who may qualify
- Ages
- 40 to 65 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Participants must be stroke patients of age 40-65 years
- Subacute Stroke
- Brunnstorm stage 3 or more than 3
Key exclusion criteria (3 listed)
- Acute stroke
- Patient unwilling to participate in study
- Cardiovascular instability
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mirror therapyalong with baseline therapeutic exercises treatment, mirror theapy is given to group 1 with 2 sets of 10 repetitions | Other | Mirror therapy |
| PNFalong with baseline therapeutic treatment ,PNF is given to group 2 with 2 sets of 10 repetitions | Other | PNF |
Primary outcome
fugl-meyer assesment scale
Time frame: 4 weeks
fugl-meyer assesment scale is used to asses motor recovery and functional in stroke patient . The results calculate on the basis of range 0-10 (severe), 11-20 (moderate), 21-28 (mild).
1 secondary outcome
Berg Balance Scale
Time frame: 4 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2026.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Stroke (CVA) or TIA
RecruitingPhase 1/2
Safety and Efficacy of CG-BM1 in Ischemic Stroke
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
RecruitingObservational study
Natural History of Stroke: Cause and Development
Brain Disease, Ischemic Attack, Transient
Not yet recruitingPhase 3
Cilostazol for Prevention of Recurrent Stroke Trial
Stroke Recurrence, Myocardial Infarction
Recruiting
Neuromodulation-Enhanced Use of RObotic BALANCE Training to Improve Balance Function in Individuals With Stroke
Stroke, Stroke (CVA) or Transient Ischemic Attack
Recruiting
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Stroke, Acute, Stroke
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Imran Rafiq, PhD Rehabilitation Sciences study director
Elite College of Management Sciences, Gujranwala
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mirror therapy and PNF in people with Stroke (CVA) or TIA, run by Elite College of Management Sciences, Gujranwala, Pakistan at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
fugl-meyer assesment scale (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2026.